7 completed, 3 unknown, 1 enrolling by invitation, 1 suspended. 12 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 12 | Completed 7, Unknown 3, Enrolling by invitation 1, Suspended 1 |
| Phase 2 | 6 | Completed 5, Unknown 1 |
Follow Hemodialysis Complication: new trials by email Literature Review of Hemodialysis Complication trials Research Report on Hemodialysis Complication
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alpha Lipoic Acid in Pediatrics on Hemodialysis Alpha lipoic acid, Placebo - Hemodialysis Complication, Pediatric Kidney Disease | Phase 3 | Enrolling by invitation | Ain Shams University | 50 | 2025-02-02 | 2026-03-02 |
| Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter Local antibiotic spray Neomycin sulphate 165,000 IU + Bacitracin zinc 12,500 IU, Mupirocin 2% ointment - Hemodialysis Complication, Hemodialysis Catheter Infection | Phase 2 / Phase 3 | Completed | Future University in Egypt | 150 | 2023-04-10 | 2023-08-22 |
| Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease L-Carnitine 500Mg thrice daily, 1g L-Carnitine IV three times a week - Hemodialysis Complication | Phase 2 / Phase 3 | Completed | Bahria University | 83 | 2023-01-01 | 2024-08-09 |
| Effect of Melatonin in Pediatric Hemodialysis Patients Melatonin, Placebo - Hemodialysis Complication, Oxidative Stress | Phase 3 | Unknown | Ain Shams University | 40 | 2022-12-01 | 2023-01-31 |
| Cholecalciferol Supplementation in Hemodialysis Patients Cholecalciferol - Anemia, Hemodialysis Complication | Phase 2 / Phase 3 | Completed | Ain Shams University | 50 | 2022-05-15 | 2023-06-28 |
| Exercise on Mitochondrial Functions of Lymphocyte in Hemodialysis Supervised exercise training, Control group - Hemodialysis Complication | Phase 3 | Completed | Chang Gung Memorial Hospital | 180 | 2021-08-01 | 2025-04-04 |
| MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD) Mannitol, 0.9% saline - Hemodialysis Complication, Hemodynamic Instability | Phase 2 / Phase 3 | Completed | Brigham and Women's Hospital | 31 | 2021-04-06 | 2025-11-24 |
| Intravenous Versus Oral Iron Therapy in Hemodialysis Patients Intravenous iron, Oral iron - Hemodialysis Complication, Anemia | Phase 3 | Unknown | Chiang Mai University | 124 | 2020-07-29 | 2020-08-11 |
| Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis Citrate Anticoagulation Solution, Control Group (heparin or continuous saline) - Hemodialysis Complication, Acute Kidney Injury | Phase 3 | Suspended | University of Sao Paulo General Hospital | 200 | 2019-02-12 | 2021-10-05 |
| Sildenafil in Hemodialysis Patients With Pulmonary Hypertension Sildenafil, Placebo - Pulmonary Hypertension, Hemodialysis Complication | Phase 2 / Phase 3 | Unknown | Ain Shams University | 60 | 2018-12-02 | 2019-01-09 |
| Cholecalciferol on Hemodialysis Patients Cholecalciferol, Placebo - Hemodialysis Complication, Vitamin D Deficiency | Phase 2 / Phase 3 | Completed | Ain Shams University | 60 | 2018-07-01 | 2019-01-09 |
| UFH is the Most Used Anticoagulant in Hemodialysis, Decreasing the Risk of Clot Formation in the Circuit. Liquaemin, Heptar - Hemodialysis Complication | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 128 | 2007-08-01 | 2021-12-27 |
Anemia (2) · Vitamin D Deficiency (2) · Acute Kidney Injury (1) · Anemia, Iron-Deficiency (1) · Hypertension, Pulmonary (1) · Inflammation (1) · Renal Insufficiency, Chronic (1) · Vascular Calcification (1)
Nutritional and Metabolic Diseases (3) · Avitaminosis (2) · Deficiency Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Malnutrition (2) · Metabolic Diseases (2) · Nutrition Disorders (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2)
Cholecalciferol (2) · Control Groups (2) · Heparin (2) · Bacitracin (1) · Carnitine (1) · Citric Acid (1) · Ferric Oxide, Saccharated (1) · Folic Acid (1) · Iron (1) · Mannitol (1) · Melatonin (1) · Mupirocin (1) · Ointments (1) · Saline Solution (1) · Sildenafil Citrate (1)
Ain Shams University (5) · Bahria University (1) · Brigham and Women's Hospital (1) · Chang Gung Memorial Hospital (1) · Chiang Mai University (1) · Eurofarma Laboratorios S.A. (1) · Future University in Egypt (1) · University of Sao Paulo General Hospital (1)
Egypt (6) · Brazil (1) · Pakistan (1) · Taiwan (1) · Thailand (1) · United States (1)
Doaa ElBohy, PhD (1) · Finnian R Mc Causland, MBBCH, MMSc (1) · Jong-Shyan Wang, PhD (1) · Kajohnsak Noppakun, MD (1) · Mahmoud Mohsen, Pharmacist (1) · Sadia Rehman (1) · Tamer W Elsaid, MD (1)
PMID 24525835, PMID 30072155, PMID 30353121, PMID 31278924, PMID 33139659, PMID 33594986, PMID 33713287, PMID 33790861, PMID 33981417, PMID 34740538, PMID 39763581, PMID 41565787, PMID 42009192